Jazz Pharmaceuticals plc (JAZZ) › Capital ExpendituresJazz Pharmaceuticals plc (JAZZ) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $20.37M2019: $40.13M2020: $15.00M2021: $27.64M2022: $29.05M2023: $23.96M2024: $38.07M2025: $58.75M$58.75M2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$58.75M+54.3%2024$38.07M+58.9%2023$23.96M-17.5%2022$29.05M+5.1%2021$27.64M+84.2%2020$15.00M-62.6%2019$40.13M+97.0%2018$20.37M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share